OpenAI filed a confidential S-1 with the SEC, targeting a fall 2026 public debut at an $852 billion valuation with Goldman Sachs and Morgan Stanley.
// daily-digest · tue 09 jun 2026 · morning refresh · last 72h focus
Seven heavy-lane items on AI IPOs, government ownership proposals, payments infrastructure, and enterprise AI cost management, two lighter pieces on AI development culture, and a medical research wildcard.
— refreshed for you, in 10 items.
OpenAI filed a confidential S-1 with the SEC, targeting a fall 2026 public debut at an $852 billion valuation with Goldman Sachs and Morgan Stanley.
The Trump administration is exploring a direct government equity stake in OpenAI as part of its broader AI investment negotiations.
Anthropic expanded Project Glasswing to 200+ organizations across 15+ countries, granting access to Claude Mythos Preview to find zero-day flaws in critical infrastructure.
Stripe, Visa, Mastercard, and Coinbase are among backers of a new stablecoin payment platform set to launch soon.
MetaMask opened early access for an agent wallet that lets AI bots execute DeFi trades across ten EVM chains inside user-defined spend and protocol rules.
Microsoft CEO Satya Nadella discusses MAI models, agent-enabled workflows, and Microsoft’s AI ecosystem strategy at Build 2026.
Uber burned its entire 2026 AI budget on Claude Code and Cursor by April, prompting a $1,500 monthly cap per employee per tool.
Simon Willison surfaces Charity Majors’s essay arguing AI optimists and skeptics talk past each other because they operate on different time horizons.
Developer catalogs twelve months of AI-assisted personal projects, from scripts to a 62,000-page auto-generated reference site.
Phase 3 trial data shows daraxonrasib nearly doubled median overall survival in metastatic pancreatic cancer from 6.7 to 13.2 months versus chemotherapy.